Watson Pays $27 Million to Exit Drug Inflation MDL

Watson Pharmaceuticals agreed to pay $27 million to settle the remaining whistleblower claims against it in the Massachusetts multidistrict litigation accusing several pharmaceutical companies of reporting inflated drug prices to Medicaid.
Law360